Effects of COVID-19 Convalescent Plasma (CCP) on Coronavirus-associated Complications in Hospitalized Patients
Clinical trial NCT04421404 · COMPLETED
Trial details
- NCT number
- NCT04421404
- Sponsor
- Priscilla Hsue, MD
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-09
- Primary completion
- 2021-04-30
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.